Comparative effectiveness of budesonide EC and telitacicept in proteinuria and eGFR trajectories in IgA nephropathy: a retrospective cohort study - Top-Institutions - MDSpire

Comparative effectiveness of budesonide EC and telitacicept in proteinuria and eGFR trajectories in IgA nephropathy: a retrospective cohort study

  • By

  • Xingsheng Zuo

  • Yaqin Wang

  • Fangfang Ma

  • Xianyuan Zhu

  • Chenglong Zhao

  • May 13, 2026

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Henan Provincial People’s Hospital
    Henan Provincial People’s Hospital

    Zhengzhou, Henan

    Key Differentiators

    • Nephrology

  • #2

    IRCCS Ospedale San Raffaele
    IRCCS Ospedale San Raffaele

    Milan, Lombardy

    Key Differentiators

    • Nephrology

  • #3

    Nagoya University Hospital
    Nagoya University Hospital

    Nagoya, Aichi

    Key Differentiators

    • Nephrology

  • #4

    University of Michigan
    University of Michigan

    Ann Arbor, Michigan

    Key Differentiators

    • Nephrology

  • #5

    CIBMTR
    CIBMTR

    Milwaukee, Wisconsin

    Key Differentiators

    • Nephrology

Original Source(s)

Comparative effectiveness of budesonide EC and telitacicept in proteinuria and eGFR trajectories in IgA nephropathy: a retrospective cohort study

  • by Xingsheng Zuo, Yaqin Wang, Fangfang Ma, Xianyuan Zhu, Chenglong Zhao

  • May 13, 2026

Related Content

7 Days Noninferior in Bacteremia

BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.

FDA Clears AI Sepsis Warning System

An FDA-cleared AI tool developed at Johns Hopkins detects sepsis up to 48 hours earlier than clinicians — and has cut related deaths by 18%.

How Social Contact Shapes Gut Microbes

Cooperative behavior linked to shared anaerobic gut bacteria

  • May 11, 2026

  • 2 min